News
Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments ...
Eli Lilly expands Zepbound access with flat-rate pricing and new vial options, supporting wider obesity treatment access ...
With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of ...
India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...
Zepbound (tirzepatide) and Wegovy (semaglutide ... Strengths are listed in milligrams per milliliter (mg/mL). Your doctor will show you or a caregiver how to inject Zepbound or Wegovy.
Tirzepatide has been approved by the ... or 15 mg per 0.5 mL in single-dose pen or single-dose vial. Learn more Zepbound is a prescription medicine. For more information, call 1-800-LillyRx ...
There are some caveats — people must pay out of pocket, or the medication is sold in a vial rather than a prefilled ... (Both contain the same active ingredient tirzepatide.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results